POU2F3 and small cell lung carcinoma: Furthermore, although a follow-up study performing immunohistochemistry (IHC) in a well-characterized patient cohort validated the presence of NEUROD1, ASCL1, and POU2F3 expressing primary SCLC tumors, a distinct YAP1 expressing SCLC subtype was not identified (8).